ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)
$50.87 -0.22 (-0.4306%)
Analysed ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) News Sources
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of SpaceX Debut
12-06-2026
yahoo.com
ELVN Stock On Track For Best Week Since March Following FDA-Aligned Path For Cancer Drug Development
12-06-2026
stocktwits.com
Enliven Therapeutics (ELVN) Soars on Stellar Leukemia Drug Trial
13-06-2026
yahoo.com
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
15-06-2026
yahoo.com
Medical Hedge Fund Sells 281,000 Shares of Enliven Theapeutics. Is it Time to Sell ELVN?
24-06-2026
fool.com
What to Know About OrbiMed's $39 Million Enliven Therapeutics Stock Sale Amid a 130% Rally
27-06-2026
fool.com
What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%
27-06-2026
fool.com
Enliven Therapeutics (ELVN) Stock Looks Overvalued As Returns Surge But Book Value Lags
04-07-2026
yahoo.com
Stocks To Watch: 14 Names Test And Tease New Buy Zones
08-07-2026
yahoo.com
HMI Capital Pares Its Stake in AI Company nCino
10-07-2026
yahoo.com
What is the current price of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The current price of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is $50.87.
ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) since the previous trading day is $-0.22.
ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) since the previous trading day is -0.4306%.
What is the most recent average sentiment score for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The most recent average sentiment score for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The most recent sentiment for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is .
SEC-8K** Filing Available For ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.